Influence of Light Exposure on Cerebral MAO-A in Seasonal Affective Disorder and Healthy Controls… (NCT02582398) | Clinical Trial Compass
CompletedNot Applicable
Influence of Light Exposure on Cerebral MAO-A in Seasonal Affective Disorder and Healthy Controls Measured by PET
Austria99 participantsStarted 2013-11
Plain-language summary
This study aims to assess differences in monoamine oxidase A (MAO-A) distribution in the brain between seasonal affective disorder patients and healthy controls using positron emission tomography. In addition the investigators aim to demonstrate the impact of light therapy on MAO-A distribution
In addition, a pilot study and a sub-study in healthy controls were performed
Who can participate
Age range18 Years – 55 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria for Patients:
* DSM-IV diagnosis of SAD established by diagnostic interview according to the SCID.
* Global Seasonality Score of 10 or higher on the Seasonal Pattern Assessment Questionnaire (SPAQ)
* Somatic health based on history, physical examination, ECG, and laboratory screening
* Aged 18 to 55 years
* No therapeutic treatment of SAD in the last 6 months (drugs and light therapy)
* Willingness and competence to complete the informed consent process
Inclusion criteria for healthy controls:
* Aged 18 to 55 years
* Somatic and psychiatric health based on history, physical examination, ECG, laboratory screening, SCID
* Willingness and competence to complete the informed consent process
Exclusion criteria for patients and healthy controls:
* Concomitant major medical or neurological illness
* Concomitant psychiatric disorders
* Current smoking
* Ingestion of antidepressants or other psychotropic agents targeting the serotonergic system, within the last 6 months.
* Bright light therapy within the last 6 months.
* Current substance abuse including alcohol, drugs of abuse, or any medication in a manner which is indicative of substance-related disorders (e.g. substance dependency) according to the DSM-IV.
* Failure to comply with the study protocol or follow the instructions of the investigators.
* Positive urine pregnancy test.
* For participants who participated in an earlier neuroimaging study using ionizing radiation, the total radiation exposure dose …
What they're measuring
1
Change in MAO-A specific distribution volume (MAO-A DVs) assessed with PET
Timeframe: PET2 (3 weeks after PET1) compared to PET 1 (baseline), PET3 (6 months after PET1) compared to PET 1 (baseline) and PET 2 (3 weeks after PET1)